MAKING PAIN
MEASURABLE
Building the first Class II FDA-cleared wearable for objective pain measurement for more accurate treatment.
OUR MISSION
Pain is the most common reason people seek medical care, yet it remains poorly understood.
1 in 4 Americans live with chronic pain and up to 80% of them are misdiagnosed. This costs the US system over $720 billion a year, and it's growing. The tools guiding this care simply haven't kept up.
NOCI exists to change that.
Meet the Team
The gold standard for pain care is still asking someone to pick a number between 0 and 10.
OBJECTIVE PAIN INTELLIGENCE FOR MORE ACCURATE TREATMENT
Clinical Grade Wearable
Continuous physiological monitoring
Patient app
Lived Experience of Pain
AI
Clinical interpretation
Objective Pain Intelligence
A structured, longitudinal pain signal that supports medical decision-making.
Patient reporting with time anchored physiology, together for the first time.
TEAM
Built by engineers, clinicians, and scientists from Weill Cornell Medicine, Harvard, Pratt, Amazon, and Medtronic, with the expertise to take NOCI from prototype to FDA clearance.
Sushir Kadidal
CEO
Designer and engineer with expertise in industrial design, data systems, and applied AI. Leading product development across hardware and software.
Harry Sin
COO
10+ years scaling hardware manufacturing at Amazon and Medtronic. Leading clinical operations and production from prototype to FDA clearance.
Bobak Mosadegh
CSO
Professor of Biomedical Engineering at Weill Cornell Medicine specializing in biosensors and medical devices. Leading scientific validation and regulatory strategy.
ADVISORS
Dr. Rohan Jotwani, MD, MBA
Interventional Pain
Specialist at Weill Cornell Medicine. Guiding clinical validation strategy and MBB pilot study design.
JoAnn Difede, PhD
Clinical Trials
Professor and Director of PATSS at Weill Cornell Medicine, with extensive NIH SBIR/STTR funding experience.
Alar Ainla, PhD
Bioelectronics
Researcher specializing in circuit design and sensor architecture for the wearable platform.
GET INVOLVED
CLINICIANS
Partner with us on early clinical validation.
INVESTORS
Back the future of pain measurement.
Contact Us
NOCI
MAKING PAIN MEASURABLE
Noci Corporation. All Rights Reserved.
MAKING PAIN
MEASURABLE
Building the first Class II FDA-cleared wearable for objective pain measurement for more accurate treatment.
OUR MISSION
Pain is the most common reason people seek medical care, yet it remains poorly understood.
1 in 4 Americans live with chronic pain and up to 80% of them are misdiagnosed. This costs the US system over $720 billion a year, and it's growing. The tools guiding this care simply haven't kept up.
NOCI exists to change that.
Meet the Team
The gold standard for pain care is still asking someone to pick a number between 0 and 10.
OBJECTIVE PAIN INTELLIGENCE FOR MORE ACCURATE TREATMENT
Clinical Grade Wearable
Continuous physiological monitoring
Patient app
Lived Experience of Pain
AI
Clinical interpretation
Objective Pain Intelligence
A structured, longitudinal pain signal that supports medical decision-making.
Patient reporting with time anchored physiology, together for the first time.
TEAM
Built by engineers, clinicians, and scientists from Weill Cornell Medicine, Harvard, Pratt, Amazon, and Medtronic, with the expertise to take NOCI from prototype to FDA clearance.
Sushir Kadidal
CEO
Designer and engineer with expertise in industrial design, data systems, and applied AI. Leading product development across hardware and software.
Harry Sin
COO
10+ years scaling hardware manufacturing at Amazon and Medtronic. Leading clinical operations and production from prototype to FDA clearance.
Bobak Mosadegh
CSO
Professor of Biomedical Engineering at Weill Cornell Medicine specializing in biosensors and medical devices. Leading scientific validation and regulatory strategy.
ADVISORS
Dr. Rohan Jotwani, MD, MBA
Interventional Pain
Specialist at Weill Cornell Medicine. Guiding clinical validation strategy and MBB pilot study design.
JoAnn Difede, PhD
Clinical Trials
Professor and Director of PATSS at Weill Cornell Medicine, with extensive NIH SBIR/STTR funding experience.
Alar Ainla, PhD
Bioelectronics
Researcher specializing in circuit design and sensor architecture for the wearable platform.
GET INVOLVED
CLINICIANS
Partner with us on early clinical validation.
INVESTORS
Back the future of pain measurement.
Contact Us
NOCI
MAKING PAIN MEASURABLE
Noci Corporation. All Rights Reserved.
MAKING PAIN
MEASURABLE
Building the first FDA-cleared Class II platform for objective pain measurement for more accurate treatment.
OUR MISSION
Pain is the most common reason people seek medical care, yet it remains poorly understood.
1 in 4 Americans live with chronic pain and up to 80% of them are misdiagnosed. This costs the US system over $720 billion a year, and it's growing. The tools guiding this care simply haven't kept up.
NOCI exists to change that.
Meet the Team
The gold standard for pain care is still asking someone to pick a number between 0 and 10.
OBJECTIVE PAIN INTELLIGENCE FOR MORE ACCURATE TREATMENT
Clinical Grade Wearable
Continuous physiological monitoring
Patient app
Lived Experience of Pain
AI
Clinical interpretation
Objective Pain Intelligence
A structured, longitudinal pain signal that supports medical decision-making.
Patient reporting with time anchored physiology, together for the first time.
TEAM
Built by engineers, clinicians, and scientists from Weill Cornell Medicine, Harvard, Pratt, Amazon, and Medtronic, with the expertise to take NOCI from prototype to FDA clearance.
Sushir Kadidal
CEO
Designer and engineer with expertise in industrial design, data systems, and applied AI. Leading product development across hardware and software.
Harry Sin
COO
10+ years scaling hardware manufacturing at Amazon and Medtronic. Leading clinical operations and production from prototype to FDA clearance.
Bobak Mosadegh
CSO
Professor of Biomedical Engineering at Weill Cornell Medicine specializing in biosensors and medical devices. Leading scientific validation and regulatory strategy.
ADVISORS
Dr. Rohan Jotwani, MD, MBA
Interventional Pain
Specialist at Weill Cornell Medicine. Guiding clinical validation strategy and MBB pilot study design.
JoAnn Difede, PhD
Clinical Trials
Professor and Director of PATSS at Weill Cornell Medicine, with extensive NIH SBIR/STTR funding experience.
Alar Ainla, PhD
Bioelectronics
Researcher specializing in circuit design and sensor architecture for the wearable platform.
GET INVOLVED
CLINICIANS
Partner with us on early clinical validation.
INVESTORS
Back the future of pain measurement.
Contact Us
NOCI
MAKING PAIN MEASURABLE
Noci Corporation. All Rights Reserved.